Published in
Oxford University Press (OUP), Neuro-Oncology, suppl 5(17), p. v200.1-v200
Links
- ORCID
- Oxford University Press (OUP) | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Rtrb-22 * Hypofractionated Radiotherapy Versus Standard Fractionated Radiotherapy With Concurrent Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma
Journal article published in 2015 by
Tony J. C. Wang,
Cheng-Chia Wu,
Ashish Jani,
Juan Estrada,
Timothy Ung,
Daniel S. Chow 
,
Jennifer Soun,
Heva J. Saadatmand,
Anurag Saraf,
Shumaila Saad,
Steven R. Isaacson,
Yasir H. Qureshi,
Simon Cheng,
Robyn Gartrell,
Michael B. Sisti
and other authors.
,
Jennifer Soun,
Heva J. Saadatmand,
Anurag Saraf,
Shumaila Saad,
Steven R. Isaacson,
Yasir H. Qureshi,
Simon Cheng,
Robyn Gartrell,
Michael B. Sisti
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Adjuvant hypofractionated radiotherapy (HRT) for elderly patients with newly diagnosed glioblastoma (GBM) is a reasonable option compared to standard fractionation radiotherapy (SRT). Outcomes in patients receiving HRT in the presence of temozolomide (TMZ) compared to SRT with TMZ is unclear. We examined HRT for GBM with TMZ in comparison to SRT with TMZ.